(Q44066018)

English

Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Emerging antimicrobial resistances among Proteus mirabilis in Europe: report from the MYSTIC Program (1997-2001). Meropenem Yearly Susceptibility Test Information Collection (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

Proteus mirabilis

object named as

Proteus mirabilis

1 reference

based on heuristic

inferred from title

author name string

Mutnick AH

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Turner PJ

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Jones RN

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

publication date

1 June 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Journal of Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

253-258

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Hospital-acquired infections: diseases with increasingly limited therapies

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Properties of multidrug-resistant, ESBL-producing Proteus mirabilis isolates and possible role of beta-lactam/beta-lactamase inhibitor combinations

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Extended-spectrum beta-lactamase in Proteus mirabilis.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

TEM-72, a new extended-spectrum beta-lactamase detected in Proteus mirabilis and Morganella morganii in Italy.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

In vitro and in vivo transferrable beta-lactam resistance due to a new plasmid-mediated oxyiminocephalosporinase from a clinical isolate of Proteus mirabilis.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Prevalence of beta-lactamases among 1,072 clinical strains of Proteus mirabilis: a 2-year survey in a French hospital

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

The MYSTIC (meropenem yearly susceptibility test information collection) programme.

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Multicenter in vitro evaluation of SM-7338, a new carbapenem

1 reference

https://api.crossref.org/works/10.1179%2FJOC.2002.14.3.253

21 January 2018

Identifiers

10.1179/JOC.2002.14.3.253

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44066018&oldid=2106196448"